Can we lower risks & increase ROIs in your portfolio? WIN-WIN Cases: Enabling Business Ventures in Seeds & Traits to Succeed Herco van Liere, VP Business Development Challenges: Risks & ROIs Investors challenge business ventures to: (*good team & exit strategy) - Focus on go-to-market (deal making) increasing company value - Handle high speed of growth to fulfill expectations - Operate lean & mean: accessing capabilities (people & tech) - ‘Guarantee’ success: but requires parallel tracks invested in - Manage added-value pipeline of new products Risks & ROIs: So what? “According to Bloomberg, 8 out of 10 entrepreneurs who start businesses fail within the first 18 months. A whopping 80% crash and burn” http://www.forbes.com/sites/ericwagner/2013/09/12/five-reasons-8-out-of-10-businesses-fail/ http://www.forbes.com/sites/georgedeeb/2013/09/18/the-unlucky-13-reasons-startups-fail/ Strategic partnering: successfully grown  Done it Case of market success: KeyGene & PollenPlus® • Problem: A fungus on rye produced toxics, forming a serious health risk, with farmers, processors losing profit: cleaning up & producing safe food • Initial KWS Solution: Resistant rye but commercially unattractive to sell due to low yield (low seed setting) • KeyGene Solution: Applying expertise & DNA technology (finding ‘KeyGenes’), enabling optimal breeding strategy: combining best of both • Result: Enabled commercial interesting hybrid rye (PollenPlus®) with increased seed setting without health risks • Financial Benefits KWS: 40% growth in rye sales (17M euro in 2008) and high marginal product Trait Development Engine in Rice & Corn Bioseed and KeyGene signed in 2012 a strategic partnership for germplasm-based development of drought tolerant crop varieties (rice & corn) for India and South-East Asia Photography: Arvid de Windt Solutions & Benefits of KeyGene (1) Solution & Benefits: KeyGene (1) – For 25 years we have grown with companies and provide them access to needed capabilities to develop their business – We have employees in various disciplines (145 PhD, BSc), they can outsource to and/or team-up with – We have state-of-the-art infrastructure, so you don’t have to invest, maintain and upgrade yourself – We own game changing technology platforms delivering you pipeline products, short cutting timelines in business Solution & Benefits of KeyGene (2) – We know how to turn technology innovation into added-value, our patent portfolio leads to services/value worth >15mEuro/yr – Straight forward business model: we partner (patented technologies, pipeline products) and you share while the value is generated (NPV-d R&D fees, MSF, royalties, IP access) Note: we are not interested in your investment in KeyGene – We have accelerated development programs (‘Booster’), such that you can build a broader pipeline of products in a faster time Opportunity: “Where can we de-risk the business development of companies you investment in while sharing their success?”